## ALGM: Allegro MicroSystems, Inc. - XLK: Technology

### Executive Summary

VALUE thesis: PEG 0.25 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates). Caution: declining volume (43% of avg), momentum weakening (-1.9% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($24.79)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 1
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. (ALGM) Risk Channels and Responsive Allocation**
- Source: Stock Traders Daily | 20251229T215800 | Bullish | Relevance: 100%
- Allegro Microsystems Inc. (NASDAQ: ALGM) is exhibiting divergent sentiment across all horizons, suggesting choppy conditions with a mid-channel oscillation pattern. The AI models have generated three distinct trading strategies (Position Trading, Momentum Breakout, and Risk Hedging) tailored to different risk profiles. A notable 73.9:1 risk-reward setup targets a 20.6% gain versus a 0.3% risk.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 1 ($0.84M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 56.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- FMR, LLC: 14.8% (+0.8%)
- Capital Research Glo: 9.1% (+5.8%)
- JPMORGAN CHASE & CO: 8.4% (+93.0%)
- Vanguard Group Inc: 7.7% (+0.6%)
- Blackrock Inc.: 6.2% (-3.5%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-1.9% 5d) with bearish MACD, trend may be turning.
2. Elevated short interest (9.2%): bears positioning against stock.
3. Market regime shift could impact high-beta names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.25 indicates undervaluation relative to growth. Forward P/E 27.6x attractive for 85% earnings growth. Balance sheet: strong liquidity (3.9x), low leverage (D/E 0.46). Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $5.0B |
| Beta | 1.62 |
| 52W Range | $16.38 - $38.45 |
| Short Interest | 9.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.25 |
| Forward P/E | 27.6 |
| Current P/E | 51.1 |
| YoY Growth | 85.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from -0.4% to -2.4% (-1.9% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 6.4pp (needs >4.0% for momentum thesis). MRS_5 turning positive (0.1%) - potential reversal signal. Below SMA200 (0.95x), long-term trend not supportive. RSI neutral at 49. Volume at 43% of 20MA suggests lack of conviction. OFD pattern: +MUL (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -2.36% (CS: 17) | Weak |
| RSI_14 | 48.7 | Neutral |
| MACD Histogram | -0.04 | Bearish |
| vs SMA20 | 0.977x | Below |
| vs SMA50 | 0.979x | Below |
| vs SMA200 | 0.951x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $26.83
- **Stop Loss:** $24.79 (7.6% risk)
- **Target:** $30.91 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 539
- **Position Value:** $14,461.37
- **Portfolio %:** 14.46%
- **Risk Dollars:** $1,100.00
- **Risk Per Trade:** 1.10%
- **Modifiers:** L1 110% | L2 100% | Combined 1.10x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.10x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk signals and moderate market participation. VIX at 14.33 indicates calm conditions, while positive yield curve (+59bps) and stable economic data support continued expansion. Year-end positioning and Fed uncertainty create near-term caution, but no systemic risks evident.*

### Earnings

**Next:** 2026-01-29 (Est: $0.14)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.12 | $0.13 | +5.4% |
| 2025Q2 | $0.08 | $0.09 | +6.5% |
| 2025Q1 | $0.05 | $0.06 | +19.6% |
| 2024Q4 | $0.06 | $0.07 | +9.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*